Supporting new business models in Life Sciences - How can Oracle help customers meet this challenge?

Join Oracle Vice President John Aisien and AstraZeneca’s Chemistry Domain Architect Nick Lynch to learn how the latest collaborative technologies are enabling life sciences organisations to innovate radical new business models.

In one information-packed morning, discover how Enterprise 2.0 tools and architectures are enabling a new era of fast, flexible and ultra-productive working. You’ll learn at first hand which technologies and approaches are enabling life sciences companies to overcome current industry challenges and work together faster, better and more profitably.

The morning’s event will finish with lunch, providing an excellent opportunity to network with your industry peers and Oracle Life Sciences experts.